SynthesisThe journal of headache and pain2025

Safety, efficacy, and compliance of moderate-to-high dose eptinezumab and erenumab in chronic migraine patients with medication-overuse headache: an updated systematic review and meta-analysis.

Nhan Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.